Trends in anemia at initiation of dialysis in the United States

Obrador, Gregorio; Roberts, Tricia; Peter, Wendy L. St.; Frazier, Eric; Pereira, Brian J.G.; Collins, Allan J.

doi:10.1046/j.1523-1755.2001.00002.x

Trends in anemia at initiation of dialysis in the United States

Journal

Kidney International

ISSN

0085-2538

Date Issued

2001

Author(s)

Obrador, Gregorio

Facultad de Ciencias de la Salud - CampCM

Roberts, Tricia

Peter, Wendy L. St.

Frazier, Eric

Pereira, Brian J.G.

Collins, Allan J.

Type

text::journal::journal article

DOI

10.1046/j.1523-1755.2001.00002.x

URL

https://scripta.up.edu.mx/handle/20.500.12552/2553

Abstract

Background: Anemia almost invariably develops in patients with chronic renal insufficiency (CRI) and is associated with a wide range of complications. The anemia of CRI can be effectively treated with recombinant human erythropoietin (rHuEPO). Recent studies suggest that the management of anemia of CRI is suboptimal in the United States. Methods: We examined the trends in hematocrit and rHuEPO use among all patients who started chronic dialysis therapy between April 1, 1995, and December 31, 1999, from the End-stage Renal Disease Medical Evidence Form 2728 submitted to the Health Care Financing Administration of the United States. Follow-up data containing hematocrit levels after initiation were obtained from the Medicare Part A institutional outpatient dialysis provider claims for 1990 to 1998 prevalent patients. © Kidney International